Trinity Biotech (TRIB) Assets (2016 - 2024)
Trinity Biotech (TRIB) has disclosed Assets for 9 consecutive years, with $103.3 million as the latest value for Q4 2024.
- Quarterly Assets rose 73.79% to $103.3 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $373.7 million through Dec 2024, changed N/A year-over-year, with the annual reading at $103.3 million for FY2024, 73.79% up from the prior year.
- Assets hit $103.3 million in Q4 2024 for Trinity Biotech, up from $59.4 million in the prior quarter.
- In the past five years, Assets ranged from a high of $130.4 million in Q4 2020 to a low of $59.4 million in Q4 2023.
- Historically, Assets has averaged $100.8 million across 5 years, with a median of $103.3 million in 2024.
- Biggest five-year swings in Assets: crashed 35.47% in 2023 and later surged 73.79% in 2024.
- Year by year, Assets stood at $130.4 million in 2020, then decreased by 8.82% to $118.9 million in 2021, then decreased by 22.53% to $92.1 million in 2022, then tumbled by 35.47% to $59.4 million in 2023, then soared by 73.79% to $103.3 million in 2024.
- Business Quant data shows Assets for TRIB at $103.3 million in Q4 2024, $59.4 million in Q4 2023, and $92.1 million in Q4 2022.